July, 1 2021 - News
Psychedelic Researcher Dr. Rosalind Watts Becomes Clinical Director to lead Retreats for Depression

Synthesis is honored to announce the addition of Dr. Rosalind Watts as the new Clinical Director, designing a retreat model with her research on psilocybin for treatment-resistant depression so Synthesis can lead the way for a new era of safe, legal and professional psychedelic experiences.

October, 23 2020 - News
Psychiatry expert Dr. Tim Read joins Synthesis as Lead Supervisor

We’re proud to welcome expert medical doctor, psychotherapist, and clinical psychiatrist Dr. Tim Read to Synthesis as the new Lead Supervisor.

August, 20 2020 - News
Leaving our Lighthouse Venue

It is with a tender heart that we say a grateful goodbye to the home of our retreats for the last two years, the sacred space of The Lighthouse.

August, 14 2020 - News
Safety First - Coronavirus Update

At Synthesis our first priority is always the safety of our participants. Read our latest announcement about the coronavirus.

May, 27 2020 - News
Letter from Synthesis co-founder Martijn Schirp about his transition from CEO to Chief Visionary Officer

With gratitude and optimism, co-founder Martijn Schirp shares an announcement on his new role transition, as Rachel Aidan becomes CEO.

February, 7 2020 - News
Welcoming Four Sigmatic's CEO & Co-Founder Tero Isokauppila to the Synthesis Advisory Board

Synthesis welcomes Tero Isokauppila to support the strategy and development of our fast-growing psilocybin retreat startup. Read more here!

December, 13 2019 - News
Documentary features Synthesis as Model for the Future of Psychedelic Retreats

This DW documentary film features an inside look inside a Synthesis Retreat and follows the journey of a man who microdoses LSD, with life-changing results.

December, 13 2019 - News
Synthesis welcomes leading Clinical Psychologist Dr. Rosalind Watts to the Advisory Board

Rosalind Watts is the Lead Clinical Psychologist at Imperial College London’s Centre for Psychedelic Research, and has been pioneering research in the therapeutic potential of psilocybin.

November, 11 2019 - News
Appointment of leading Psychedelics Neuroscientist, Dr. Robin Carhart-Harris, to Advisory Board

Synthesis welcomes neuroscientist Dr. Robin Carhart-Harris to support the strategy, research, and development of our fast-growing psilocybin retreat start-up. Find out more about how his